Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

20.06.2022

1 AJR Am J Roentgenol
2 Am J Respir Crit Care Med
1 Ann Intern Med
2 Antiviral Res
7 BMJ
11 Clin Infect Dis
1 Emerg Infect Dis
2 Infect Control Hosp Epidemiol
4 Int J Infect Dis
1 Intensive Care Med
7 J Infect
4 J Med Virol
1 J Travel Med
2 J Virol
8 JAMA
4 Lancet
2 Lancet Infect Dis
1 Life Sci
6 N Engl J Med
4 Nature
2 Radiology
2 Science



    AJR Am J Roentgenol

  1. LITTLE BP
    Editorial Comment: Influential Images-CT Shows Lower Severity of COVID-19 Pneumonia in Vaccinated Patients.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.28103.
    >> Share


    Am J Respir Crit Care Med

  2. KOOISTRA E, Heesakkers H, Pickkers P, Zegers M, et al
    Long-Term Impairments are Most Pronounced in Critically Ill COVID-19 Patients with Severe Obesity.
    Am J Respir Crit Care Med. 2022 Jun 13. doi: 10.1164/rccm.202202-0376.
    >> Share

  3. BARNETT CR, Segal LN
    Untangling Lower Airway Dysbiosis in Critically-Ill COVID-19 Patients.
    Am J Respir Crit Care Med. 2022 Jun 13. doi: 10.1164/rccm.202206-1074.
    >> Share


    Ann Intern Med

  4. PALMORE TN, Henderson DK
    Adding New Fuel to the Fire: Monkeypox in the Time of COVID-19-Implications for Health Care Personnel.
    Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-1763.
    >> Share


    Antiviral Res

  5. MELO-FILHO CC, Bobrowski T, Martin HJ, Sessions Z, et al
    Conserved coronavirus proteins as targets of broad-spectrum antivirals.
    Antiviral Res. 2022 Jun 9:105360. doi: 10.1016/j.antiviral.2022.105360.
    >> Share

  6. MERCORELLI B, Desantis J, Celegato M, Bazzacco A, et al
    Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization.
    Antiviral Res. 2022;204:105350.
    >> Share


    BMJ

  7. BABICKI M, Mastalerz-Migas A
    Providing care for those fleeing war: challenges and solutions for Polish doctors looking after refugees from Ukraine.
    BMJ. 2022;377:o1440.
    >> Share

  8. MAZZILLI S, Moazen B, Stover H, Plugge E, et al
    Covid-19 vaccine in prison: a not-to-be-missed opportunity to promote access to vaccination in adolescents.
    BMJ. 2022;377:o1439.
    >> Share

  9. DYER C
    Covid-19: Unusable PPE worth pound4bn will be burned, says spending watchdog.
    BMJ. 2022;377:o1435.
    >> Share

  10. HITCHINGS MDT, Ranzani OT, Lind ML, Dorion M, et al
    Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.
    BMJ. 2022;377:e070102.
    >> Share

  11. WISE J
    Covid-19: Patients without respiratory symptoms no longer have to wear a face mask in GP surgeries.
    BMJ. 2022;377:o1445.
    >> Share

  12. ADAB P, Haroon S, O'Hara ME, Jordan RE, et al
    Comorbidities and covid-19.
    BMJ. 2022;377:o1431.
    >> Share

  13. WISE J
    Covid-19: Omicron infection is poor booster to immunity, study finds.
    BMJ. 2022;377:o1474.
    >> Share


    Clin Infect Dis

  14. RANGANATH N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, et al
    Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.
    Clin Infect Dis. 2022 Jun 14. pii: 6607746. doi: 10.1093.
    >> Share

  15. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  16. WEGRZYN RD, Appiah GD, Morfino R, Milford SR, et al
    Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605116. doi: 10.1093.
    >> Share

  17. LIND ML, Schultes OL, Robertson AJ, Houde AJ, et al
    Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities.
    Clin Infect Dis. 2022 Jun 10. pii: 6605088. doi: 10.1093.
    >> Share

  18. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  19. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  20. MILLER MJ, Himschoot A, Fitch N, Jawalkar S, et al
    Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605073. doi: 10.1093.
    >> Share

  21. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  22. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  23. MILLER AD, Yousaf AR, Bornstein E, Wu MJ, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605071. doi: 10.1093.
    >> Share

  24. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  25. METZ AR, Bauer M, Epperly C, Stringer G, et al
    Investigation of COVID-19 Outbreak among Wildland Firefighters during Wildfire Response, Colorado, USA, 2020.
    Emerg Infect Dis. 2022;28.
    >> Share


    Infect Control Hosp Epidemiol

  26. BULNES R, Said M, Bronstein M, Gutowski J, et al
    Benefit and Cost of Repeating a SARS-CoV-2 PCR after the Second Day of Hospitalization in 5 Hospitals during Various Community Prevalences and Vaccination Rates.
    Infect Control Hosp Epidemiol. 2022 Jun 16:1-14. doi: 10.1017/ice.2022.
    >> Share

  27. RHEE C, Baker MA, Klompas M
    Survey of COVID-19 Infection Control Policies at Leading U.S. Academic Hospitals in the Context of the Initial Omicron Surge.
    Infect Control Hosp Epidemiol. 2022 Jun 16:1-29. doi: 10.1017/ice.2022.
    >> Share


    Int J Infect Dis

  28. CLARO F, Silva D, Bogado JAP, Rangel HR, et al
    Lasting SARS-CoV-2 specific IgG Antibody response in health care workers from Venezuela, 6 months after vaccination with Sputnik V.
    Int J Infect Dis. 2022 Jun 8. pii: S1201-9712(22)00341.
    >> Share

  29. TARNAS MC, Desai AN, Parker DM, Almhawish N, et al
    Syndromic surveillance of respiratory infections during protracted conflict: experiences from northern Syria 2016-2021.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00336.
    >> Share

  30. SASANAMI M, Kayano T, Nishiura H
    Monitoring the COVID-19 immune landscape in Japan.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00338.
    >> Share

  31. MANNATHOKO N, Mospele M, Gross R, Smith RM, et al
    Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) and Carbapenem-Resistant Enterobacterales (CRE) in Healthcare and Community Settings in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Int J Infect Dis. 2022 Jun 7. pii: S1201-9712(22)00337.
    >> Share


    Intensive Care Med

  32. VIEILLARD-BARON A, Huang S
    Characterising right ventricular dysfunction in COVID-19 ARDS: which measurements are the best? Author's reply.
    Intensive Care Med. 2022 Jun 9. pii: 10.1007/s00134-022-06774.
    >> Share


    J Infect

  33. YUAN W, Hou Y, Lin Q, Chen L, et al
    How China responds to Omicron.
    J Infect. 2022;85:90-122.
    >> Share

  34. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Reduced neutralizing antibody response in naive Covishield vaccinees against Omicron emphasizes booster vaccination.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00213.
    >> Share

  35. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    >> Share

  36. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    >> Share

  37. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    >> Share

  38. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    >> Share

  39. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    >> Share


    J Med Virol

  40. LYTRAS T, Kontopidou F, Lambrou A, Tsiodras S, et al
    Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27934.
    >> Share

  41. ATLURI VL, Stalter RM, McGuffin SA, Johnson L, et al
    Patient Characteristics Associated with Conversion from Negative to Positive SARS-CoV2 PCR Test Results: Implications for Clinical False-Negativity from a Single-Center: A Case-Control Study.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27932.
    >> Share

  42. RUDIANSYAH M, Jasim SA, Mohammad Pour ZG, Athar SS, et al
    Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    J Med Virol. 2022 Jun 10. doi: 10.1002/jmv.27929.
    >> Share

  43. KUMAR S, Karuppanan K, Subramaniam G
    Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    J Med Virol. 2022 Jun 9. doi: 10.1002/jmv.27927.
    >> Share


    J Travel Med

  44. BAI Y, Du Z, Xu M, Sc M, et al
    International risk of SARS-CoV-2 omicron variant importations originating in South Africa.
    J Travel Med. 2022 Jun 15. pii: 6608762. doi: 10.1093.
    >> Share


    J Virol

  45. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    >> Share

  46. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    >> Share


    JAMA

  47. VIJAY A, Yancy CW
    Resident Physician Wellness Postpandemic: How Does Healing Occur?
    JAMA. 2022;327:2077-2078.
    >> Share

  48. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    >> Share

  49. GANDHI RT, Malani PN, Del Rio C
    COVID-19 Treatments for Nonhospitalized Patients-Reply.
    JAMA. 2022;327:2248.
    >> Share

  50. CAYLEY WE JR
    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2248.
    >> Share

  51. FARMAKIOTIS D
    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2247.
    >> Share

  52. LARKIN HD
    Urine Test Detects SARS-CoV-2 Antibodies.
    JAMA. 2022;327:2182.
    >> Share

  53. HAMAD R, Galea S
    The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
    JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.
    >> Share

  54. KLOMPAS M, Pandolfi MC, Nisar AB, Baker MA, et al
    Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.
    JAMA. 2022 Jun 15. pii: 2793582. doi: 10.1001/jama.2022.9609.
    >> Share


    Lancet

  55. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    >> Share

  56. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    >> Share

  57. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    >> Share

  58. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    >> Share


    Lancet Infect Dis

  59. YAMASOBA D, Kosugi Y, Kimura I, Fujita S, et al
    Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies.
    Lancet Infect Dis. 2022 Jun 8. pii: S1473-3099(22)00365.
    >> Share

  60. BLOM K, Marking U, Havervall S, Norin NG, et al
    Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.
    Lancet Infect Dis. 2022 Jun 9. pii: S1473-3099(22)00362.
    >> Share


    Life Sci

  61. GUPTA A, Jayakumar MN, Saleh MA, Kannan M, et al
    SARS-CoV-2-infection induced growth factors play differential roles in COVID-19 pathogenesis.
    Life Sci. 2022 Jun 11:120703. doi: 10.1016/j.lfs.2022.120703.
    >> Share


    N Engl J Med

  62. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    >> Share

  63. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    >> Share

  64. MATUCHANSKY C
    Protection against SARS-CoV-2 after Vaccination and Previous Infection.
    N Engl J Med. 2022;386.
    >> Share

  65. HOPKINS S, Hall V, Klenerman P
    Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
    N Engl J Med. 2022;386.
    >> Share

  66. QU P, Faraone J, Evans JP, Zou X, et al
    Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2206725.
    >> Share

  67. LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
    Association between Covid-19 Vaccination and Influenza Vaccination Rates.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
    >> Share


    Nature

  68. MARSHALL M
    COVID and smell loss: answers begin to emerge.
    Nature. 2022 Jun 9. pii: 10.1038/d41586-022-01589.
    >> Share

  69. BAKER N, Wolf L
    Coronapod: COVID and smell loss, what the science says.
    Nature. 2022 Jun 10. pii: 10.1038/d41586-022-01648.
    >> Share

  70. SIDIK SM
    New COVID drugs face delays as trials grow more difficult.
    Nature. 2022 Jun 13. pii: 10.1038/d41586-022-01602.
    >> Share

  71. VOHRINGER HS, Sanderson T, Sinnott M, De Maio N, et al
    Publisher Correction: Genomic reconstruction of the SARS CoV-2 epidemic in England.
    Nature. 2022 Jun 7. pii: 10.1038/s41586-022-04887.
    >> Share


    Radiology

  72. ROGERS P, Walker I, Yeung J, Khan A, et al
    Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Radiology. 2022 Jun 14:220365. doi: 10.1148/radiol.220365.
    >> Share

  73. ALEXANDER R, Waite S, Bruno MA, Krupinski EA, et al
    Mandating Limits on Workload, Duty, and Speed in Radiology.
    Radiology. 2022 Jun 14:212631. doi: 10.1148/radiol.212631.
    >> Share


    Science

  74. SAAD-ROY CM, Metcalf CJE, Grenfell BT
    Immuno-epidemiology and the predictability of viral evolution.
    Science. 2022;376:1161-1162.
    >> Share

  75. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016